Antisoma to present at J.P. Morgan Healthcare Conference

London, UK, and Cambridge, MA: Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that its Chief Executive Officer, Glyn Edwards, will present an overview of the Company’s strategy, programmes and prospects at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco, on Thursday, January 14th at 11:30 PST/19:30 GMT.

A webcast of the presentation will be available on Antisoma’s website at http://www.antisoma.com/asm/media/webcast/

For live viewing of the webcast, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software.

Background on Antisoma
Antisoma is a London Stock Exchange-listed biopharmaceutical company that develops novel products for the treatment of cancer. The Company has operations in the UK and the US. Please visit www.antisoma.com for further information about Antisoma.